The month of May was bustling in the cannabis space. During that time, the Investing News Network (INN) covered the introduction of new cannabis brands from Organigram Holdings (TSXV:OGI) and National Access Cannabis (TSXV:META) as part of the larger branding strategy seen in the industry.
Other big news came on May 15, when CannTrust Holdings (TSX:TRST) increased its production expectations for its new Niagara Greenhouse facility as part of its 2018 first-quarter financial and operational results. The licensed producer (LP) reported revenue of over C$7.8 million and now believes its facility will be capable of delivering 50,000 kilograms of cannabis per year.
In the video above, INN brings investors in the cannabis space an update on some of the biggest developments in the public markets during the month of May. Watch for more insight on what happened in the public space last month.
In a blockbuster deal similar to the CanniMed acquisition, Aurora Cannabis (TSX:ACB) revealed the details of a purchase for MedReleaf (TSX:LEAF), a respected and up until recently medically focused cannabis LP. The deal was inked at a reported C$3.2 billion and will expand production capacity for Aurora.
On the consolidation activity seen so far this year in the space, Aaron Salz, CEO of Stoic Advisory, a firm working with cannabis companies on corporate finance, told INN that some of the driving forces behind M&A activity are “some of the larger companies attempting to extend their reach.”
Salz spoke to INN at the Lift & Co. Expo in Toronto about the future for middle and small companies in the public market and what new investors should keep in mind when entering the volatile space. Watch the interview below for more on what Salz had to say.
As a last highlight during the month of May, INN reported on increasingly bullish sentiment, expressed by an investing panel during Lift, towards US-focused companies raising capital through the Canadian Securities Exchange (CSE), the only Canadian public exchange allowing these companies to do so.
Barrington Miller, director of listed company services for the CSE, told INN he sees the increased potential of the US government to address the status of the drug on a federal level as the cause for this newfound interest in the stocks.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.